The Future of Health Care: The Promise of Clinical Trials in Advancing Cancer Care

Pre-Registration has now closed. You may register day of the event at acscan.windrosemedia.com

On December 3rd, the American Cancer Society Cancer Action Network (ACS CAN) will host, in virtual format, our 5th annual forum in Connecticut to examine the current impact and future potential of clinical trials in cancer care, with a focus on disparities and barriers for patient participation. 

Focus of the Forum

This event will examine the importance of cancer clinical trials and the key barriers that result in approximately 20% of cancer clinical trials never beginning due to lack of enrollment. Overcoming these barriers and increasing cancer clinical trial access to disparate populations will ensure that cancer research becomes more efficient, reducing the time and effort needed to translate basic science discoveries into meaningful therapeutic advances that benefit all patients. Forum participants will include key stakeholders throughout the oncology community, including leaders in life sciences, health care systems, academia, provider groups, patient advocacy, public policy, business, and others.  ACS CAN will use this event to help illustrate and explore the following:

• Are current eligibility criteria preventing willing patients from enrolling in trials? What still needs to be done?

• What role do healthcare institutions play in clinical trial enrollment and success?

• What improvements need to be made so that disparate populations have access to clinical trials.

• What is the long-term impact of COVID-19 on clinical trials;

• How do everyday issues, such as location, transportation, childcare affect access for patients to potential new treatments through clinical trials.

• The work ACS CAN is doing to increase access to clinical trials.

Pre-Registration has now closed. You may register day of the event at acscan.windrosemedia.com

Speakers

Andrea Silber, MD - Assistant Clinical Director for Health Equity and Diversity, Yale Cancer Center

Jose DeJesus - Community Health Educator, Yale School of Public Health

Pratheesh Sathyan, PhD - Sr. Medical Science Liaison, Foundation Medicine

Jessica Mary Clement, MD - Medical Director, Cancer Clinical Trials, Hartford HealthCare Cancer Institute

Tushemia Roberts, RN - Breast Cancer Survivor

State Senator Saud Anwar, MD (3^rd Senate District) - Vice Chair, Public Health Committee

State Representative William Petit, MD (22nd District) - House Ranking Member, Public Health Committee

Sponsorship Opportunities

ACS CAN is committed to ensuring that our progress to prevent cancer and save more lives continues by collaborating with key partners.  We invite you and your organization to join us in the fight against cancer by sponsoring this year’s event. 

To learn more about sponsorship opportunities click here.

We would like to thank our sponsors:

Gold Sponsors:

Silver Sponsors:

Pfizer

Boehringer Ingelheim

GlaxoSmithKline 

Bronze Sponsors:

Novartis

Merck

Genentech

Janssen Oncology 

PhRMA

American Cancer Society Cancer Action Network

ACS CAN is the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society and is the nation’s leading cancer advocacy organization working every day to make cancer priorities a state and national priority.  ACS CAN is committed to ensuring that our progress on critical policy issues is achieved in collaboration with key partners.  We invite you to join us in this critical dialogue and help us all save more lives from cancer. 

For more information contact Bryte Johnson

[email protected]

Contributions or membership payments to the American Cancer Society Cancer Action Network, Inc. are not tax deductible.